Dementia and Alzheimers

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/35

encourage image

There's no tags or description

Looks like no tags are added yet.

36 Terms

1
New cards

Dementia

A chronic, progressive syndrome characterized by a irreversible decline in cognitive function, impairment of memory, and loss of brain function that interferes with daily living and occupational capabilities. 

2
New cards

Alzheimer’s Disease (AD)

The most common form of dementia. Changes begin decades before clinical symptoms appear; significant, irreversible neuronal damage is present at diagnosis. 

3
New cards

Amyloid Beta Plaques

Abnormal protein clumps accumulating in extracellular spaces between neurons. 

4
New cards

Neurofibrillary Tau Tangles

Twisted protein fibers forming inside damaged neurons. 

5
New cards

Neuroinflammation

A chronic inflammatory response triggered by plaques and tangles that accelerates cell damage. 

6
New cards

Vicious Cycle & Cerebral Atrophy

Ongoing neuroinflammation, plaque, and tangle accumulation cause mass neuron death, leading to severe cerebral atrophy, loss of synaptic connections, physical decline, and death. 

7
New cards

Non-Modifiable Risk Factors: 

  • Age: Single greatest risk factor (risk rises significantly after age 65). 

  • Genetics & Family History: Apolipoprotein E (APOE-ε4) gene increases risk up to 4x; first-degree relative history. 

  • Sex: Females > Males (partially due to longer average lifespan). 


8
New cards

Modifiable / Lifestyle Risk Factors- Cardiovascular & Metabolic

Mid-life hypertension, type 2 diabetes, obesity, hyperlipidemia, stroke history. 

9
New cards

Modifiable / Lifestyle Risk Factors- Lifestyle

Physical inactivity, smoking, alcohol abuse, poor diet (high saturated fat/sugar/salt), untreated obstructive sleep apnea. 

10
New cards

Modifiable / Lifestyle Risk Factors- Sensory & Social

Hearing loss, vision loss, social isolation, low lifelong cognitive engagement. 

11
New cards

Modifiable / Lifestyle Risk Factors- Mental Health & Safety

Depression in mid/late life, repeated traumatic brain injury (TBI)/head trauma. 

12
New cards

Modifiable / Lifestyle Risk Factors- Environmental

High exposure to fine particle air pollution near heavy traffic corridors. 

13
New cards

Stage 1: Mild (Early Stage) key manifestations

Mild short-term memory loss, misplacing household objects, difficulty finding words/terms in conversation, subtle changes in judgment, trouble planning or performing familiar tasks independently.

14
New cards

Stage 2: Moderate (Middle Stage) key manifestations

Noticeable mood/personality shifts (agitation, paranoia), confusion regarding time or place, difficulty speaking, reading, or writing, inability to perform complex tasks or managing personal finances independently.

15
New cards

Stage 3: Severe (Late Stage) key manifestations

Complete loss of ability to perform Activities of Daily Living (ADLs), loss of swallowing/chewing reflex (high aspiration risk), incontinence (bowel and bladder), loss of recognition of family members, immobility.

16
New cards

Diagnostics

is achieved by ruling out reversible causes (e.g., Delirium, Depression, Thyroid dysfunction, Vitamin B12 deficiency) and confirming cognitive impairment. 

17
New cards

Clinical Assessment & History

History of onset, duration, and progression of behavioral changes, functional assessment, and standardized tool screening (e.g., MMSE). 

18
New cards

CT / MRI

Evaluates structural brain shrinkage (atrophy) or rules out mass lesions and strokes. 

19
New cards

PET Scan

Visualizes abnormal accumulation of amyloid plaques or tau tangles in brain tissue. 

20
New cards

Lumbar Puncture (LP)

Measures elevated CSF amyloid-beta and tau protein levels. 

21
New cards

Laboratory Testing

  • CBC, CMP, TSH, Vitamin B12, Urinalysis, and blood biomarker tests (e.g., elevated p-tau217 levels). 

  • Genetic testing (APOE). 


22
New cards

Safety First

Keep bed in lowest position, place fall-risk alarms, ensure well-lit environment, remove scatter rugs, and secure doors if wandering occurs. 

23
New cards

Environment & Routine

Provide a structured, predictable routine with minimal changes; assign consistent caregivers to decrease anxiety and confusion. 

24
New cards

Validation Therapy vs. Reorientation- Mild Stage

Reorient frequently to time, place, and person using clocks, calendars, and signs. 

25
New cards

Validation Therapy vs. Reorientation- Moderate to Severe Stage

Use Validation Therapy—validate feelings rather than arguing or forcing reality when the patient is agitated or delusional. 

26
New cards

Communication Strategies

  • Speak calmly using short, simple, direct sentences and clear statements. 

  • Give one direct instruction at a time and allow extra response time. 

  • Avoid complex choices, direct confrontations, or arguing. 


27
New cards

Supportive Care

  • Assist with ADLs while promoting maximum independence for safe activities. 

  • Screen for caregiver burden/burnout; refer to community resources (e.g., Alzheimer’s Association, National Institute on Aging, respite care, support groups). 


28
New cards

Cholinesterase Inhibitors 

Generic (Brand): Donepezil, Rivastigmine 

29
New cards

Cholinesterase Inhibitors key mechanism

Prevents breakdown of acetylcholine to slow cognitive decline. 

30
New cards

Cholinesterase Inhibitors- Nursing Considerations & Client Education

Take at bedtime (Donepezil) to reduce fall risk from bradycardia/syncope. Side effects include GI distress (nausea, vomiting, diarrhea), bradycardia, and dizziness. Monitor heart rate and weight regularly. 

31
New cards

NMDA Receptor Antagonists 

Generic (Brand): Memantine

32
New cards

NMDA Receptor Antagonists- Key Mechanism

Regulates glutamate activity to slow cell damage in moderate-to-severe AD. 

33
New cards

NMDA Receptor Antagonists- Nursing Considerations & Client Education

Can be given alongside cholinesterase inhibitors. Monitor for dizziness, confusion, and headache. Administer cautiously in renal impairment. 

34
New cards

SSRIs 

Generic (Brand): Sertraline 

35
New cards

SSRIs- Key Mechanism

Manages secondary depressive symptoms and mood disturbances

36
New cards

SSRIs- Nursing Considerations & Client Education

  • Monitor for serotonin syndrome and increased fall risk. Instruct family that therapeutic effect takes 2–4 weeks.